# OnCo record breast-cancer (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/breast-cancer/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "breast-cancer" ;
  schema:name "Breast cancer (all types)"@en ;
  schema:alternateName "TCGA-BRCA"@en, "breast invasive carcinoma (TCGA BRCA cohort)"@en, "Breast carcinoma"@en, "Carcinoma of the breast"@en ;
  schema:description "Breast cancer is not one disease, and the result that decides which page you need is the receptor result: whether the cancer carries oestrogen and progesterone receptors, and whether it carries too much HER2. Those two answers give four boxes, not three, with a page for each. Grade and stage do not change which page you read; they change what happens on it."@en ;
  schema:url <https://onco.cc/cancers/breast-cancer/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Breast_cancer> ;
  schema:citation <https://en.wikipedia.org/wiki/Breast_cancer>, <https://www.cancer.gov/types/breast>, <https://www.nice.org.uk/guidance/ng101/chapter/recommendations>, <https://www.rcpath.org/resourceLibrary/g148-dataset-for-histopathological-reporting-of-breast-disease-in-surgical-excision-specimens-of-breast-cancer.html>, <https://www.nice.org.uk/guidance/cg81/chapter/Diagnosis-and-assessment>, <https://doi.org/10.1002/ijc.70561>, <https://www.uicc.org/what-we-do/sharing-knowledge/tnm>, <https://doi.org/10.1111/his.70149>, <https://doi.org/10.1111/his.14091>, <https://doi.org/10.1111/j.1365-2559.1991.tb00229.x>, <https://doi.org/10.1007/bf01840834>, <https://doi.org/10.1200/jco.19.02309>, <https://doi.org/10.1136/jcp-2022-208632>, <https://doi.org/10.1093/jnci/djx273>, <https://seer.cancer.gov/statfacts/html/breast-subtypes.html>, <https://seer.cancer.gov/statfacts/html/breast.html>, <https://gco.iarc.who.int/media/globocan/factsheets/cancers/20-breast-fact-sheet.pdf>, <https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/breast-cancer>, <https://www.cancerresearchuk.org/about-cancer/breast-cancer/types>, <https://www.nhs.uk/conditions/breast-cancer/symptoms/>, <https://www.nhs.uk/conditions/breast-cancer-in-women/>, <https://www.nhs.uk/conditions/breast-cancer-in-women/tests-and-next-steps-for-breast-cancer-in-women/>, <https://www.nhs.uk/conditions/breast-cancer-in-women/treatment-for-breast-cancer-in-women/>, <https://www.nhs.uk/conditions/breast-cancer-in-women/help-and-support-for-breast-cancer-in-women/>, <https://www.nhs.uk/conditions/breast-cancer-in-men/>, <https://www.nhs.uk/tests-and-treatments/mastectomy/>, <https://www.nhs.uk/conditions/lymphoedema/>, <https://www.nhs.uk/conditions/lymphoedema/treatment/>, <https://www.nhs.uk/conditions/cellulitis/>, <https://www.nhs.uk/conditions/menopause-and-perimenopause/symptoms/>, <https://www.nhs.uk/conditions/sepsis/>, <https://www.nhs.uk/tests-and-treatments/clinical-trials/>, <https://www.nhs.uk/nhs-services/urgent-and-emergency-care-services/when-to-use-111/>, <https://www.nhs.uk/nhs-services/urgent-and-emergency-care-services/when-to-call-999/>, <https://www.nhs.uk/social-care-and-support/support-and-benefits-for-carers/carer-assessments/>, <https://www.nhs.uk/social-care-and-support/support-and-benefits-for-carers/benefits-for-carers/>, <https://www.nice.org.uk/guidance/ng101/chapter/Recommendations>, <https://www.nice.org.uk/guidance/ng257/chapter/Fertility-preservation-for-medical-indications>, <https://www.nice.org.uk/guidance/ng234/chapter/Recommendations>, <https://www.nice.org.uk/guidance/cg151>, <https://www.macmillan.org.uk/cancer-information-and-support/treatments-and-drugs/breast-conserving-surgery-for-breast-cancer>, <https://www.macmillan.org.uk/cancer-information-and-support/treatments-and-drugs/removing-the-breast-mastectomy>, <https://www.macmillan.org.uk/cancer-information-and-support/breast-cancer/breast-reconstruction>, <https://www.macmillan.org.uk/cancer-information-and-support/treatments-and-drugs/surgery-to-the-lymph-nodes-for-breast-cancer>, <https://www.macmillan.org.uk/cancer-information-and-support/treatments-and-drugs/radiotherapy-for-breast-cancer>, <https://www.macmillan.org.uk/cancer-information-and-support/impacts-of-cancer/lymphoedema>, <https://www.macmillan.org.uk/cancer-information-and-support/impacts-of-cancer/hair-loss>, <https://www.macmillan.org.uk/cancer-information-and-support/impacts-of-cancer/fertility>, <https://www.macmillan.org.uk/cancer-information-and-support/impacts-of-cancer/sepsis>, <https://www.macmillan.org.uk/cancer-information-and-support/impacts-of-cancer/work-and-cancer>, <https://www.macmillan.org.uk/cancer-information-and-support/supporting-someone/looking-after-someone-with-cancer>, <https://www.macmillan.org.uk/cancer-information-and-support/treatment/your-treatment-options/questions-to-ask-your-healthcare-team>, <https://www.cancerresearchuk.org/about-cancer/breast-cancer/treatment/surgery/breast-reconstruction>, <https://www.cancerresearchuk.org/about-cancer/breast-cancer/living-with/life-after-surgery>, <https://www.cancerresearchuk.org/about-cancer/breast-cancer/treatment/surgery/after-surgery/problems-after-mastectomy>, <https://www.cancerresearchuk.org/about-cancer/breast-cancer/living-with/preserving-fertility>, <https://www.cancerresearchuk.org/about-cancer/breast-cancer/living-with/menopausal-symptoms>, <https://www.cancerresearchuk.org/about-cancer/breast-cancer/living-with/lymphoedema-after-treatment>, <https://www.cancerresearchuk.org/about-cancer/breast-cancer/treatment/radiotherapy/radiotherapy-treatment>, <https://www.cancerresearchuk.org/about-cancer/treatment/prehabilitation>, <https://breastcancernow.org/about-breast-cancer/treatment/lymphoedema>, <https://breastcancernow.org/about-breast-cancer/treatment/surgery-for-primary-breast-cancer>, <https://breastcancernow.org/about-breast-cancer/secondary-breast-cancer/secondary-breast-cancer-symptoms>, <https://breastcancernow.org/about-breast-cancer/life-after-treatment/coping-with-breast-cancer-emotionally>, <https://www.maggies.org/support-and-information/>, <https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/breast-cancer/incidence-invasive>, <https://doi.org/10.1056/NEJMoa020989>, <https://doi.org/10.1056/NEJMoa022152>, <https://doi.org/10.1016/S0140-6736(11)61629-2>, <https://doi.org/10.1016/S1470-2045(13)70076-7>, <https://doi.org/10.1200/JCO.22.01565>, <https://doi.org/10.1001/jama.2017.11470>, <https://doi.org/10.1056/NEJMoa2313487>, <https://doi.org/10.1056/NEJMoa2412063>, <https://doi.org/10.1001/jama.2009.1568>, <https://doi.org/10.1056/NEJMoa1413204>, <https://doi.org/10.1200/JCO.2018.78.0858>, <https://doi.org/10.1002/onco.13690>, <https://doi.org/10.1001/jama.2016.20939> ;
  onco:tag "parent-page" ;
  onco:related <https://onco.cc/cancers/her2-low-metastatic-breast-cancer/>, <https://onco.cc/cancers/inflammatory-breast-cancer/>, <https://onco.cc/cancers/paget-disease-of-the-nipple/>, <https://onco.cc/cancers/phyllodes-tumour/>, <https://onco.cc/cancers/male-breast-cancer/>, <https://onco.cc/cancers/ductal-carcinoma-in-situ/>, <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/breast-her2-positive/>, <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/invasive-breast-carcinoma-no-special-type/>, <https://onco.cc/cancers/invasive-lobular-carcinoma/>, <https://onco.cc/cancers/lobular-carcinoma-in-situ/>, <https://onco.cc/cancers/medullary-pattern-breast-carcinoma/> ;
  onco:technologies <https://onco.cc/technologies/mammography/>, <https://onco.cc/technologies/ultrasound/>, <https://onco.cc/technologies/mri/>, <https://onco.cc/technologies/ct/>, <https://onco.cc/technologies/pet-ct/>, <https://onco.cc/technologies/histopathology-ihc/>, <https://onco.cc/technologies/digital-pathology-ai/>, <https://onco.cc/technologies/palliative-care/>, <https://onco.cc/technologies/psycho-oncology/>, <https://onco.cc/technologies/peer-support-groups/>, <https://onco.cc/technologies/oncology-nutrition/>, <https://onco.cc/technologies/pain-management/>, <https://onco.cc/technologies/survivorship-care-plan/>, <https://onco.cc/technologies/multidisciplinary-tumour-board/>, <https://onco.cc/technologies/financial-navigation/>, <https://onco.cc/technologies/cbt-fatigue-distress/>, <https://onco.cc/technologies/exercise-during-chemotherapy/>, <https://onco.cc/technologies/prehabilitation/>, <https://onco.cc/technologies/lymphoedema-decongestive-therapy/>, <https://onco.cc/technologies/scalp-cooling/>, <https://onco.cc/technologies/fertility-preservation/> ;
  onco:terms <https://onco.cc/terms/terminal-duct-lobular-unit/>, <https://onco.cc/terms/who-breast-classification/>, <https://onco.cc/terms/nottingham-grade/>, <https://onco.cc/terms/nottingham-prognostic-index/>, <https://onco.cc/terms/tnm-breast-cancer-editions/>, <https://onco.cc/terms/grade-stage-receptor-breast/>, <https://onco.cc/terms/er-pr-scoring-breast/>, <https://onco.cc/terms/her2-testing-uk-breast/>, <https://onco.cc/terms/receptor-conversion-breast/>, <https://onco.cc/terms/breast-tumour-size-on-the-report/>, <https://onco.cc/terms/hormone-receptor-status/>, <https://onco.cc/terms/her2-positive/>, <https://onco.cc/terms/her2-low/>, <https://onco.cc/terms/er-pr-negative-threshold/>, <https://onco.cc/terms/ajcc-prognostic-stage-breast/>, <https://onco.cc/terms/tumour-grade/>, <https://onco.cc/terms/grade-vs-stage/>, <https://onco.cc/terms/cancer-stage/>, <https://onco.cc/terms/tnm-staging/>, <https://onco.cc/terms/carcinoma-in-situ/>, <https://onco.cc/terms/dcis/>, <https://onco.cc/terms/lymphovascular-invasion/>, <https://onco.cc/terms/lymph-node-status/>, <https://onco.cc/terms/sentinel-lymph-node-biopsy/>, <https://onco.cc/terms/core-needle-biopsy/>, <https://onco.cc/terms/ihc/>, <https://onco.cc/terms/fish/>, <https://onco.cc/terms/pcr/>, <https://onco.cc/terms/rcb/>, <https://onco.cc/terms/basal-like/>, <https://onco.cc/terms/pam50/>, <https://onco.cc/terms/interval-breast-cancer/>, <https://onco.cc/terms/ki-67-in-tnbc/>, <https://onco.cc/terms/breast-conserving-surgery-versus-mastectomy/>, <https://onco.cc/terms/oncoplastic-breast-surgery/>, <https://onco.cc/terms/axillary-surgery-de-escalation/>, <https://onco.cc/terms/targeted-axillary-dissection/>, <https://onco.cc/terms/breast-cancer-related-lymphoedema/>, <https://onco.cc/terms/breast-reconstruction/>, <https://onco.cc/terms/bia-alcl/>, <https://onco.cc/terms/radiotherapy-omission-early-breast-cancer/>, <https://onco.cc/terms/partial-breast-irradiation/>, <https://onco.cc/terms/tumour-bed-boost/>, <https://onco.cc/terms/post-mastectomy-radiotherapy/>, <https://onco.cc/terms/neoadjuvant-versus-adjuvant-breast/>, <https://onco.cc/terms/late-effects/>, <https://onco.cc/terms/quality-of-life/>, <https://onco.cc/terms/curative-intent/>, <https://onco.cc/terms/cancer-related-fatigue/>, <https://onco.cc/terms/febrile-neutropenia/>, <https://onco.cc/terms/bone-metastases/>, <https://onco.cc/terms/brain-metastases/>, <https://onco.cc/terms/metastatic-spinal-cord-compression/> ;
  onco:trials <https://onco.cc/trials/ibis-i/>, <https://onco.cc/trials/ibis-ii/>, <https://onco.cc/trials/agex/>, <https://onco.cc/trials/start-b/>, <https://onco.cc/trials/fast-forward/>, <https://onco.cc/trials/import-low/> ;
  onco:pipeline <https://onco.cc/drugs/trastuzumab-deruxtecan/>, <https://onco.cc/drugs/datopotamab-deruxtecan/>, <https://onco.cc/technologies/oral-serds/> ;
  onco:standardOfCare <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/breast-her2-positive/>, <https://onco.cc/cancers/tnbc/>, <https://onco.cc/technologies/hypofractionated-radiotherapy/>, <https://onco.cc/cancers/ductal-carcinoma-in-situ/>, <https://onco.cc/technologies/histopathology-ihc/>, <https://onco.cc/terms/core-needle-biopsy/>, <https://onco.cc/terms/fish/>, <https://onco.cc/terms/er-pr-scoring-breast/>, <https://onco.cc/terms/her2-testing-uk-breast/>, <https://onco.cc/terms/nottingham-grade/>, <https://onco.cc/technologies/ultrasound/>, <https://onco.cc/technologies/mri/>, <https://onco.cc/technologies/ct/>, <https://onco.cc/technologies/pet-ct/>, <https://onco.cc/terms/tnm-breast-cancer-editions/>, <https://onco.cc/terms/nottingham-prognostic-index/>, <https://onco.cc/terms/grade-stage-receptor-breast/>, <https://onco.cc/terms/receptor-conversion-breast/>, <https://onco.cc/terms/core-needle-biopsy/>, <https://onco.cc/terms/her2-low/>, <https://onco.cc/trials/nsabp-b06/>, <https://onco.cc/trials/milan-i/>, <https://onco.cc/trials/eortc-10801/>, <https://onco.cc/trials/nsabp-b04/>, <https://onco.cc/terms/lumpectomy/>, <https://onco.cc/terms/mastectomy/>, <https://onco.cc/terms/breast-conserving-surgery-versus-mastectomy/>, <https://onco.cc/terms/oncoplastic-breast-surgery/>, <https://onco.cc/terms/resection-margins/>, <https://onco.cc/terms/lumpectomy/>, <https://onco.cc/cancers/ductal-carcinoma-in-situ/>, <https://onco.cc/terms/breast-conserving-surgery-versus-mastectomy/>, <https://onco.cc/trials/nsabp-b32/>, <https://onco.cc/trials/almanac/>, <https://onco.cc/trials/sound/>, <https://onco.cc/trials/insema/>, <https://onco.cc/terms/sentinel-lymph-node-biopsy/>, <https://onco.cc/technologies/sentinel-node/>, <https://onco.cc/terms/axillary-surgery-de-escalation/>, <https://onco.cc/trials/acosog-z0011/>, <https://onco.cc/trials/senomac/>, <https://onco.cc/trials/amaros/>, <https://onco.cc/trials/ibcsg-23-01/>, <https://onco.cc/trials/posnoc/>, <https://onco.cc/terms/lymphadenectomy/>, <https://onco.cc/terms/breast-cancer-related-lymphoedema/>, <https://onco.cc/terms/axillary-surgery-de-escalation/>, <https://onco.cc/trials/acosog-z1071/>, <https://onco.cc/trials/targeted-axillary-dissection-md-anderson/>, <https://onco.cc/trials/nsabp-b51/>, <https://onco.cc/trials/atnec/>, <https://onco.cc/terms/targeted-axillary-dissection/>, <https://onco.cc/terms/neoadjuvant-versus-adjuvant-breast/>, <https://onco.cc/trials/nsabp-b06/>, <https://onco.cc/trials/eortc-22881-boost/>, <https://onco.cc/terms/tumour-bed-boost/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/terms/radiotherapy-omission-early-breast-cancer/>, <https://onco.cc/trials/start-a/>, <https://onco.cc/trials/start-b/>, <https://onco.cc/trials/fast-trial/>, <https://onco.cc/trials/fast-forward/>, <https://onco.cc/technologies/hypofractionated-radiotherapy/>, <https://onco.cc/terms/hypofractionation/>, <https://onco.cc/terms/deep-inspiration-breath-hold/>, <https://onco.cc/terms/alpha-beta-ratio/>, <https://onco.cc/trials/import-low/>, <https://onco.cc/trials/rapid/>, <https://onco.cc/trials/nsabp-b39/>, <https://onco.cc/trials/targit-a/>, <https://onco.cc/terms/partial-breast-irradiation/>, <https://onco.cc/technologies/intraoperative-radiotherapy/>, <https://onco.cc/trials/calgb-9343/>, <https://onco.cc/trials/prime-ii/>, <https://onco.cc/trials/lumina/>, <https://onco.cc/terms/radiotherapy-omission-early-breast-cancer/>, <https://onco.cc/technologies/active-surveillance/>, <https://onco.cc/trials/supremo/>, <https://onco.cc/trials/ma-20/>, <https://onco.cc/trials/eortc-22922/>, <https://onco.cc/trials/nsabp-b51/>, <https://onco.cc/terms/post-mastectomy-radiotherapy/>, <https://onco.cc/terms/mastectomy/>, <https://onco.cc/trials/mroc/>, <https://onco.cc/trials/ibra-study/>, <https://onco.cc/trials/pre-bra/>, <https://onco.cc/trials/best-bra/>, <https://onco.cc/terms/breast-reconstruction/>, <https://onco.cc/terms/bia-alcl/>, <https://onco.cc/terms/mastectomy/>, <https://onco.cc/terms/neoadjuvant-versus-adjuvant-breast/>, <https://onco.cc/terms/neoadjuvant-adjuvant/>, <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/breast-her2-positive/>, <https://onco.cc/cancers/tnbc/>, <https://onco.cc/terms/pcr/>, <https://onco.cc/terms/rcb/>, <https://onco.cc/terms/lumpectomy/>, <https://onco.cc/terms/mastectomy/>, <https://onco.cc/terms/breast-margins-and-re-excision/>, <https://onco.cc/technologies/hypofractionated-radiotherapy/>, <https://onco.cc/trials/fast-forward/>, <https://onco.cc/trials/start-b/>, <https://onco.cc/trials/import-low/>, <https://onco.cc/trials/prime-ii/>, <https://onco.cc/trials/lumina/>, <https://onco.cc/terms/curative-intent/>, <https://onco.cc/technologies/multidisciplinary-tumour-board/>, <https://onco.cc/technologies/prehabilitation/>, <https://onco.cc/terms/breast-reconstruction/>, <https://onco.cc/terms/mastectomy/>, <https://onco.cc/terms/lumpectomy/>, <https://onco.cc/terms/body-image-after-breast-surgery/>, <https://onco.cc/terms/numbness-after-breast-surgery/>, <https://onco.cc/cancers/male-breast-cancer/>, <https://onco.cc/technologies/psycho-oncology/>, <https://onco.cc/technologies/peer-support-groups/>, <https://onco.cc/terms/sentinel-lymph-node-biopsy/>, <https://onco.cc/terms/lymphadenectomy/>, <https://onco.cc/technologies/sentinel-node/>, <https://onco.cc/terms/lymphoedema-after-breast-cancer/>, <https://onco.cc/terms/cording-axillary-web-syndrome/>, <https://onco.cc/terms/seroma-after-breast-surgery/>, <https://onco.cc/technologies/lymphoedema-decongestive-therapy/>, <https://onco.cc/technologies/hypofractionated-radiotherapy/>, <https://onco.cc/terms/late-effects/>, <https://onco.cc/technologies/fertility-preservation/>, <https://onco.cc/terms/menopause-after-chemotherapy-breast/>, <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/male-breast-cancer/>, <https://onco.cc/technologies/cbt-fatigue-distress/>, <https://onco.cc/technologies/psycho-oncology/>, <https://onco.cc/terms/numbness-after-breast-surgery/>, <https://onco.cc/terms/body-image-after-breast-surgery/>, <https://onco.cc/terms/breast-reconstruction/>, <https://onco.cc/terms/menopause-after-chemotherapy-breast/>, <https://onco.cc/cancers/male-breast-cancer/>, <https://onco.cc/technologies/psycho-oncology/>, <https://onco.cc/technologies/peer-support-groups/>, <https://onco.cc/terms/quality-of-life/>, <https://onco.cc/terms/hair-loss-and-scalp-cooling-breast/>, <https://onco.cc/technologies/scalp-cooling/>, <https://onco.cc/technologies/psycho-oncology/>, <https://onco.cc/technologies/peer-support-groups/>, <https://onco.cc/technologies/survivorship-care-plan/>, <https://onco.cc/terms/late-effects/>, <https://onco.cc/terms/bone-metastases/>, <https://onco.cc/terms/brain-metastases/>, <https://onco.cc/terms/metastatic-spinal-cord-compression/>, <https://onco.cc/terms/lymphoedema-after-breast-cancer/>, <https://onco.cc/technologies/palliative-care/>, <https://onco.cc/technologies/financial-navigation/>, <https://onco.cc/terms/work-and-money-breast-cancer-uk/>, <https://onco.cc/terms/carers-breast-cancer-uk/> .